Compare FSSL & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FSSL | BVS |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 884.4M | 892.4M |
| IPO Year | 2025 | 2016 |
| Metric | FSSL | BVS |
|---|---|---|
| Price | $11.57 | $14.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.60 |
| AVG Volume (30 Days) | 248.1K | ★ 362.4K |
| Earning Date | 01-01-0001 | 11-06-2026 |
| Dividend Yield | ★ 15.05% | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.52 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $6.46 |
| Revenue Next Year | N/A | $6.74 |
| P/E Ratio | ★ $9.70 | $28.82 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.75 | $6.47 |
| 52 Week High | $14.49 | $15.89 |
| Indicator | FSSL | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 48.36 | 61.05 |
| Support Level | $11.31 | $12.43 |
| Resistance Level | $11.92 | $14.92 |
| Average True Range (ATR) | 0.23 | 0.50 |
| MACD | 0.02 | 0.18 |
| Stochastic Oscillator | 45.69 | 76.87 |
FS Specialty Lending Fund is a United States-based externally managed, non-diversified, closed-end management investment company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation by investing mainly in private and public credit in a broad set of industries, sectors, and sub-sectors. Its investment policy is to invest mainly in a portfolio of secured and unsecured floating and fixed-rate loans, bonds, and other types of credit instruments, which, under normal circumstances, will represent at least eighty percent of the Company's total assets.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.